Møller N - Search Results

1

Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.

Jørgensen JO, Møller N, Lauritzen T, Alberti KG, Orskov H, Christiansen JS. Jørgensen JO, et al. Among authors: moller n. J Clin Endocrinol Metab. 1990 Jan;70(1):207-14. doi: 10.1210/jcem-70-1-207. J Clin Endocrinol Metab. 1990. PMID: 2294131 Clinical Trial.

2

Preservation of inherent diurnal serum insulin-like growth factor binding protein 1 pattern during low dose GH infusion.

Jørgensen JO, Møller N, Bang P, Hall K. Jørgensen JO, et al. Among authors: moller n. Horm Metab Res. 1992 Oct;24(10):496-7. doi: 10.1055/s-2007-1003372. Horm Metab Res. 1992. PMID: 1281460 No abstract available.

3

A comparison of four methods for assessing in vivo beta-cell function in normal, obese and non-insulin-dependent diabetic man.

Davis SN, Piatti PM, Monti L, Möller N, Ng LL, Coppack S, Antsiferov M, Brown MD, Alberti KG. Davis SN, et al. Among authors: moller n. Diabetes Res. 1992 Mar;19(3):107-17. Diabetes Res. 1992. PMID: 1286545 Clinical Trial.

4

[Diabetes and diet--does the rationale hold even in the 1990's?].

Møller N, Schmitz OE, Christiansen JS, Orskov H. Møller N, et al. Ugeskr Laeger. 1992 Sep 14;154(38):2579-80. Ugeskr Laeger. 1992. PMID: 1413188 Danish. No abstract available.

5

Lack of effects of hypoglycemia on glucose absorption in healthy men.

Møller J, Laker MF, Gillespie SM, Ovesen PG, Abildgaard N, Tian R, Jørgensen JO, Møller N. Møller J, et al. Among authors: moller n. Diabetes Care. 1992 Oct;15(10):1264-6. doi: 10.2337/diacare.15.10.1264. Diabetes Care. 1992. PMID: 1425086

6

Octreotide and diabetes: theoretical and experimental aspects.

Orskov H, Flyvbjerg A, Frystyk J, Ledet T, Møller N, Christensen SE, Harris AG. Orskov H, et al. Among authors: moller n. Metabolism. 1992 Sep;41(9 Suppl 2):66-71. doi: 10.1016/0026-0495(92)90034-8. Metabolism. 1992. PMID: 1518436 Review.

7

Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.

Møller N, Schmitz O, Jøorgensen JO, Astrup J, Bak JF, Christensen SE, Alberti KG, Weeke J. Møller N, et al. J Clin Endocrinol Metab. 1992 May;74(5):1012-9. doi: 10.1210/jcem.74.5.1569148. J Clin Endocrinol Metab. 1992. PMID: 1569148

8

Effects of growth hormone administration on fuel oxidation and thyroid function in normal man.

Møller J, Jørgensen JO, Møller N, Christiansen JS, Weeke J. Møller J, et al. Among authors: moller n. Metabolism. 1992 Jul;41(7):728-31. doi: 10.1016/0026-0495(92)90312-x. Metabolism. 1992. PMID: 1619991 Clinical Trial.

9

Effects of a physiological growth hormone pulse on substrate metabolism in insulin-dependent (type 1) diabetic subjects.

Møller N, Schmitz O, Møller J, Butler PC. Møller N, et al. Among authors: moller j. J Clin Endocrinol Metab. 1992 Aug;75(2):432-6. doi: 10.1210/jcem.75.2.1639944. J Clin Endocrinol Metab. 1992. PMID: 1639944

10

Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia; evidence for increased muscle glucose uptake.

Møller N, Blum WF, Mengel A, Hansen LB, Alberti KG, Schmitz O. Møller N, et al. Diabetologia. 1991 Jan;34(1):17-20. doi: 10.1007/BF00404019. Diabetologia. 1991. PMID: 1647334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

686 results

Search Page

Filters